Third subject treated in MAPS Flagship MDMA Study

The third subject in the MDMA/PTSD study participated in the second (and final) experimental session. The experimental sessions have all been scheduled on Fridays, which is working out to be a convenient time and gives subjects the weekend to rest and reflect.